1 |
Identification of novel genetic markers associated with clinical phenotypes of systemic sclerosis through a genome-wide association strategy.
|
|
|
|
BASE
|
|
Show details
|
|
2 |
Polymorphisms in the interleukin 4, interleukin 13 and corresponding receptor genes are not associated with systemic sclerosis and do not influence gene expression
|
|
|
|
BASE
|
|
Show details
|
|
3 |
Analysis of the influence of PTPN22 gene polymorphisms in systemic sclerosis
|
|
|
|
BASE
|
|
Show details
|
|
4 |
Variants of PBEF predispose to systemic sclerosis and pulmonary arterial hypertension development
|
|
|
|
BASE
|
|
Show details
|
|
5 |
A replication study confirms the association of TNFSF4 (OX40L) polymorphisms with systemic sclerosis in a large European cohort
|
|
|
|
BASE
|
|
Show details
|
|
6 |
Identification of novel genetic markers associated with clinical phenotypes of systemic sclerosis through a genome-wide association strategy
|
|
|
|
BASE
|
|
Show details
|
|
7 |
Identification of Novel Genetic Markers Associated with Clinical Phenotypes of Systemic Sclerosis through a Genome-Wide Association Strategy
|
|
|
|
In: PLoS Genetics, 14-07-2011 (2011)
|
|
BASE
|
|
Show details
|
|
8 |
Analysis of the influence of PTPN22 gene polymorphisms in systemic sclerosis
|
|
|
|
BASE
|
|
Show details
|
|
9 |
Identification of novel genetic markers associated with the clinical phenotypes of systemic sclerosis through a genome wide association strategy
|
|
|
|
BASE
|
|
Show details
|
|
10 |
Analysis of the influence of PTPN22 gene polymorphisms in systemic sclerosis
|
|
Diaz-Gallo, LM; Gourh, P; Broen, J; Simeon, C; Fonollosa, V; Ortego-Centeno, N; Agarwal, S; Vonk, MC; Coenen, M; Riemekasten, G; Hunzelmann, N; Hesselstrand, R; Tan, FK; Reveille, JD; Assassi, S; García-Hernandez, FJ; Carreira, P; Camps, MT; Fernandez-Nebro, A; de la Peña, P Garcia; Nearney, T; Hilda, D; González-Gay, MA; Airo, P; Beretta, L; Scorza, R; Herrick, A; Worthington, J; Pros, A; Gómez-Gracia, I; Trapiella, L; Espinosa, G; Castellvi, I; Witte, T; de Keyser, F; Vanthuyne, M; Mayes, MD; Radstake, TRDJ; Arnett, FC; Martin, J; Rueda, B. - 2010
|
|
Keyword:
Article
|
|
URL: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3170726 http://www.ncbi.nlm.nih.gov/pubmed/21131644 https://doi.org/10.1136/ard.2010.130138
|
|
BASE
|
|
Hide details
|
|
11 |
Variants of PBEF predispose to systemic sclerosis and pulmonary arterial hypertension development
|
|
|
|
BASE
|
|
Show details
|
|
12 |
Polymorphisms in the interleukin 4, interleukin 13 and corresponding receptor genes are not associated with Systemic Sclerosis and do not influence gene expression
|
|
|
|
BASE
|
|
Show details
|
|
13 |
The STAT4 gene influences the genetic predisposition to systemic sclerosis phenotype
|
|
|
|
BASE
|
|
Show details
|
|
14 |
The STAT4 gene influences the genetic predisposition to systemic sclerosis phenotype
|
|
|
|
BASE
|
|
Show details
|
|
15 |
A large multicentre analysis of CTGF -945 promoter polymorphism does not confirm association with systemic sclerosis susceptibility or phenotype
|
|
|
|
BASE
|
|
Show details
|
|
16 |
The interleukin 23 receptor gene does not confer risk to systemic sclerosis and is not associated with systemic sclerosis disease phenotype
|
|
|
|
BASE
|
|
Show details
|
|
17 |
The Interleukin 23 Receptor gene does not confer risk to systemic sclerosis and is not associated with SSc disease phenotype
|
|
|
|
BASE
|
|
Show details
|
|
18 |
A large multicenter analysis of CTGF -945 promoter polymorphism does not confirm association with Systemic Sclerosis susceptibility or phenotype
|
|
|
|
BASE
|
|
Show details
|
|
19 |
A large multicenter analysis of CTGF -945 promoter polymorphism does not confirm association with Systemic Sclerosis susceptibility or phenotype
|
|
|
|
BASE
|
|
Show details
|
|
|
|